Clinical Trials In Rhode Island

Discover hundreds of clinical trials in Rhode Island.
Search clinical trials in Rhode Island by city, condition or phase.

e.g. Respiratory Diseases

Rhode Island•Healthy volunteers: No

Filter results

Results: 445

Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy

Recruiting

Phase 2

Sponsor:

Waihong Chung

Location:

Providence

Code:

NCT03840057

Conditions

Gastro Intestinal Bleeding

Upper Gastrointestinal Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Azithromycin Injection

Metoclopramide Injectable Solution

Sodium chloride 0.9%

Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence

Recruiting

Sponsor:

Gnankang Sarah Napoe

Location:

Providence, Pittsburgh

Code:

NCT03535857

Conditions

Overactive Bladder Syndrome

Urinary Incontinence, Urge

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

PTNS

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected Pancreatic Ductal Adenocarcinoma

Recruiting

Phase 2

Sponsor:

Genentech, Inc.

Location:

Providence, Los Angeles, Newport Beach, San Franciscoshow 20 more

Code:

NCT05968326

Conditions

Adenocarcinoma, Pancreatic Ductal

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Autogene cevumeran

Atezolizumab

mFOLFIRINOX

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Providence, East Providence, Fairhope, Phoenixshow 106 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior

Recruiting

Phase 2

Sponsor:

The Miriam Hospital

Location:

Providence, Boston

Code:

NCT06547320

Conditions

Overweight and Obesity

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Eat Less Intervention

Eat Slower Intervention

e.g. Respiratory Diseases

Rhode Island•Healthy volunteers: No

Filter results

Results: 445

Metoclopramide, Azithromycin, or Nondrug Pretreatment for UGIB to Reduce Second Endoscopy

Recruiting

Phase 2

Sponsor:

Waihong Chung

Location:

Providence

Code:

NCT03840057

Conditions

Gastro Intestinal Bleeding

Upper Gastrointestinal Bleeding

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Azithromycin Injection

Metoclopramide Injectable Solution

Sodium chloride 0.9%

Effectiveness of Bilateral PTNS Compared to Unilateral PTNS for the Treatment of Overactive Bladder/Urge Incontinence

Recruiting

Sponsor:

Gnankang Sarah Napoe

Location:

Providence, Pittsburgh

Code:

NCT03535857

Conditions

Overactive Bladder Syndrome

Urinary Incontinence, Urge

Eligibility Criteria

Sex: Female

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

PTNS

A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected Pancreatic Ductal Adenocarcinoma

Recruiting

Phase 2

Sponsor:

Genentech, Inc.

Location:

Providence, Los Angeles, Newport Beach, San Franciscoshow 20 more

Code:

NCT05968326

Conditions

Adenocarcinoma, Pancreatic Ductal

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Autogene cevumeran

Atezolizumab

mFOLFIRINOX

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Providence, East Providence, Fairhope, Phoenixshow 106 more

Code:

NCT06268873

Conditions

Chronic Kidney Disease and Hypertension

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Baxdrostat/dapagliflozin

Dapagliflozin in combination with placebo

Sensor-based Just-in Time Adaptive Interventions (JITAIs) Targeting Eating Behavior

Recruiting

Phase 2

Sponsor:

The Miriam Hospital

Location:

Providence, Boston

Code:

NCT06547320

Conditions

Overweight and Obesity

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Eat Less Intervention

Eat Slower Intervention